Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement and complement inhibitors: their role in autoimmune and inflammatory diseases

N S Sheerin1, S H Sacks

  • 1Department of Nephrology and Transplantation, United Medical and Dental School, Guy's Hospital, London, UK.

Current Opinion in Nephrology and Hypertension
|June 9, 1998
PubMed
Summary

Complement activation drives kidney injury, with chronic damage and local complement synthesis offering new therapeutic targets. Complement-based therapies are being developed for both transplant and native kidney diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement activation and kidney transplantation; a complex relationship.

Immunobiology·2023
Same author

A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function.

PloS one·2021
Same author

Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Complement-here, there and everywhere, but what about the transplanted organ?

Seminars in immunology·2016
Same author

Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.

Transplantation proceedings·2015
Same author

De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Nephrology
  • Immunology
  • Pathogenesis of Renal Injury

Background:

  • The complement system plays a critical role in the development of kidney injury.
  • Recent advancements, including knockout technology and specific inhibitors, are confirming this role.
  • Chronic renal injury, particularly affecting tubules and interstitium, is increasingly recognized.

Purpose of the Study:

  • To highlight the confirmed role of complement in renal injury pathogenesis.
  • To identify chronic injury and local complement synthesis as potential therapeutic targets.
  • To discuss the development of complement-based therapies for kidney diseases.

Main Methods:

  • Utilizing knockout technology to investigate complement's role.
  • Employing specific complement inhibitors in studies.

Related Experiment Videos

  • Analyzing chronic injury patterns in tubules and interstitium.

    • Main Results:

    • Confirmation of complement's pathogenic role in renal injury.
    • Identification of chronic tubulointerstitial injury as a key feature.
    • Emerging evidence for local complement synthesis in kidney disease.

    Conclusions:

    • Complement is a validated target for therapeutic intervention in renal injury.
    • Targeting chronic injury and local complement synthesis presents new therapeutic avenues.
    • Complement-based strategies are under development for native and transplant kidney protection.